FDA Adverse Event Injury Summary report: N

COREVALVE TRANSCATHETER AORTIC VALVE

MDR report key: 10126111 · Received June 5, 2020

Report

Report Number
2025587-2020-01818
Event Type
Injury
Date Received
June 5, 2020
Date of Event
March 29, 2019
Report Date
June 5, 2020
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PO
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: NASCIMENTO H ET AL. TAVI IN TAVI: NEW PARADIGM. ACTA CARDIOLOGICA. 2020; 75(2):172-174. DOI: 10.1080/00015385.2019.1569311. EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A (B)(6)-YEAR-OLD MALE PATIENT WITH A MEDICAL HISTORY OF SEVERE AORTIC STENOSIS WHO UNDERWENT IMPLANT OF A 29MM MEDTRONIC COREVALVE TRANSCATHETER VALVE. NO SERIAL NUMBERS WERE PROVIDED. IMMEDIATELY POST IMPLANT, A MILD PARAVALVULAR LEAK WAS OBSERVED BECAUSE OF ITS RELATIVELY LOW POSITION IN THE AORTIC ANNULUS. A FEW MONTHS LATER, THE PATIENT DEVELOPED PROGRESSIVE HEART FAILURE AND THE PARAVALVULAR LEAK ADVANCED TO SEVERE. THE PATIENT ALSO HAS LEFT VENTRICULAR DILATION AND MODERATE-SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION. A BALLOON POST-DILATION WAS UNSUCCESSFUL, AND ULTIMATELY A NON-MEDTRONIC TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
588108 COREVALVE TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION CRS

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention